A new wave of potentially curative treatments called Advanced Therapy Medicinal Products (ATMPs) has the potential to transform the lives of patients and revolutionise the way we think, manage and resource healthcare.
EFPIA members have come together to propose a concrete list of recommendations that could accelerate the availability and increase patient access to these ground-breaking treatments.
Welcome IHI
This week we celebrated the launch of the Innovative Health Initiative, the new health public-private partnership bringing together the pharmaceutical, biotech, digital and medtech sectors, along with academics, patients the European Commission to create a world-leading cross-sectorial partnership.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.